Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.35 |
| ▸ | HMGCR | P04035 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17633700 | 0.98 | PTPN7 (0.38) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL17633747 | 0.93 | TSHR (0.33) | HMGCR | |
| SCHEMBL8517564 | 0.84 | — | — | |
| SCHEMBL19283051 | 0.80 | PTPN7 (0.36) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL17633795 | 0.78 | PTPN7 (0.39) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL17633756 | 0.74 | — | — | |
| SCHEMBL17633754 | 0.73 | TSHR (0.35) | HMGCR | |
| SCHEMBL2121918 | 0.72 | PTPN7 (0.40) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL3796995 | 0.70 | PTPN7 (0.43) | PTPN7HMGCRRECQLTDP1KDM4E | |
| SCHEMBL5865499 | 0.70 | PTPN7 (0.43) | PTPN7HMGCRRECQLTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11033889-B2 | Palladium acyclic diaminocarbene complexes as precatalysts for Hiyama coupling and the tandem one-pot fluoride free Hiyama coupling/cyclization for the synthesis of biologically relevant | INDIAN INSTITUTE OF TECHNOLOGY BOMBAY (IN) | 2021-06-15 | — | — | US | disclosed |
| US-11028256-B2 | Silica-containing rubber compositions containing specified coupling agents and related methods | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2021-06-08 | — | — | US | disclosed |
| US-20200122132-A1 | PALLADIUM ACYCLIC DIAMINOCARBENE COMPLEXES AS PRECATALYSTS FOR HIYAMA COUPLING AND THE TANDEM ONE-POT FLUORIDE FREE HIYAMA COUPLING/CYCLIZATION FOR THE SYNTHESIS OF BIOLOGICALLY RELEVANT | INDIAN INSTITUTE OF TECHNOLOGY BOMBAY (IN) | 2020-04-23 | — | — | US | disclosed |
| US-20200123349-A1 | SILICA-CONTAINING RUBBER COMPOSITIONS CONTAINING SPECIFIED COUPLING AGENTS AND RELATED METHODS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2020-04-23 | — | — | US | disclosed |
| US-20170247532-A1 | SILICA-CONTAINING RUBBER COMPOSITIONS CONTAINING SPECIFIED COUPLING AGENTS AND RELATED METHODS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC | 2017-08-31 | — | — | US | disclosed |
| EP-3197950-A1 | SILICA-CONTAINING RUBBER COMPOSITIONS CONTAINING SPECIFIED COUPLING AGENTS AND RELATED METHODS | Bridgestone Americas Tire Operations, LLC (US) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016048935-A1 | SILICA-CONTAINING RUBBER COMPOSITIONS CONTAINING SPECIFIED COUPLING AGENTS AND RELATED METHODS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2016-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200122132-A1 | PALLADIUM ACYCLIC DIAMINOCARBENE COMPLEXES AS PRECATALYSTS FOR HIYAMA COUPLING AND THE TANDEM ONE-POT FLUORIDE FREE HIYAMA COUPLING/CYCLIZATION FOR THE SYNTHESIS OF BIOLOGICALLY RELEVANT | PAICS, AOC1, FLI1 | PTPN7 4173/4885HMGCR 3627/4885RECQL 472/4885 |
| US-11033889-B2 | Palladium acyclic diaminocarbene complexes as precatalysts for Hiyama coupling and the tandem one-pot fluoride free Hiyama coupling/cyclization for the synthesis of biologically relevant | PAICS, AOC1, FLI1 | PTPN7 4173/4885HMGCR 3627/4885RECQL 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.